The FDA approved tapinarof cream 1% (VTAMA; Organon) today to treat patients aged 2 and older with atopic dermatitis. Ahead ...

and treatment options. Atopic dermatitis (AD) is the most common type of eczema, so some people simply call it eczema. It causes people’s skin to become discolored, itchy, cracked, and dry.

This latest approval is the second indication of the monoclonal antibody, Nemluvio. It was first approved in Aug. 2024 to ...

Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic skin conditi ...

Atopic dermatitis is the most common type ... but it can spread to other places in the body without early detection and treatment. Which skin disease cannot be cured? Cold sores, psoriasis ...

The US Food and Drug Administration (FDA) has approved nemolizumab for moderate-to-severe atopic dermatitis inadequately ...

According to newly published research, the exposure to nature provided by the Re-Connecting Nature forest microbe extract has ...

With over 1,100 subjects enrolled across 39 clinical study sites, the company is developing and validating the study.

The US Food and Drug Administration (FDA) has approved Vtama (tapinarof) cream 1%, an aryl hydrocarbon receptor agonist, for ...

Andrew Rosenberg, DVM, and Adam Christman, DVM, MBA, talk about shortcomings of treatments approved for canine allergic and ...

The U.S. Food and Drug Administration has approved Nemluvio (nemolizumab) for the treatment of moderate-to-sev ...